Myotonic dystrophy type 1 as a major risk factor for severe COVID-19?

The coronavirus disease 2019 (COVID-19) pandemic is challenging health care systems worldwide. People with myotonic dystrophy type 1 (DM1) represent a high-risk population during infectious disease outbreaks, little is known about the potential impact of COVID-19 on patients with DM1. We studied the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhont, Sebastiaan, Callens, Rutger, Stevens, Dieter, Bauters, Fre, De Bleecker, Jan L., Derom, Eric, Van Braeckel, Eva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556549/
https://www.ncbi.nlm.nih.gov/pubmed/33052531
http://dx.doi.org/10.1007/s13760-020-01514-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7556549/
https://www.ncbi.nlm.nih.gov/pubmed/33052531
http://dx.doi.org/10.1007/s13760-020-01514-z

Ejemplares similares